Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Chime Biologics Announces Strategic Cooperation with Leads Biolabs and BeiGene to Advance LBL-007 mAb Development and Manufacturing Globally 2023-06-30 20:15
Transcenta Presented PFS Data by CLDN18.2 Expression Level from Phase I/II Study of Osemitamab (TST001) plus CAPOX as the First-Line Treatment of Advanced G/GEJ Cancer at ESMO GI Annual Congress 2023 2023-06-30 17:33
Harbour BioMed Announces Biologics License Application Acceptance of Batoclimab for Treatment of Generalized Myasthenia Gravis by NMPA 2023-06-29 21:26
HaemaLogiX Announces Positive Final Results from KappaMab Combination Phase IIb Myeloma Trial 2023-06-29 19:00
CPHI & PMEC China 2023 to launch international roadshow in Guangzhou 2023-06-29 18:10
Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore 2023-06-29 17:14
Jacobio Pharma Presents Clinical Results of Glecirasib in Colorectal Cancer 2023-06-29 16:31
Clarity establishes a US Center of Excellence for Targeted Copper Theranostics 2023-06-28 20:58
Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development 2023-06-28 20:00
Caliway Announces Positive Data from CBL-0201EFP Phase 2-Stage 1 Study of CBL-514 in Treating Moderate to Severe Cellulite 2023-06-28 18:30
Nuance Pharma's Partner Verona Pharma Submits New Drug Application to US FDA for Ensifentrine for the Maintenance Treatment of COPD 2023-06-28 17:07
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA 2023-06-28 09:57
LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma 2023-06-28 04:00
First Drug Discovered and Designed with Generative AI Enters Phase II Trials, with First Patients Dosed 2023-06-27 21:00
EXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TEST 2023-06-27 19:00
Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership 2023-06-27 15:33
Lion TCR Secures USD 40 million Series B2 Financing, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy 2023-06-27 08:30
CStone announces GAVRETO® (pralsetinib) sNDA approval by China NMPA for first-line treatment of patients with locally advanced or metastatic RET fusion-positive non-small cell lung cancer 2023-06-27 08:05
New ZIRCON Phase III Data Presented at SNMMI: Potential Utility of TLX250-CDx in Staging and Monitoring ccRCC 2023-06-27 03:51
HitGen launches a newly upgraded version of OpenDEL™, a self-service screening kit, to facilitate innovative drug discovery research 2023-06-26 21:30
1 101 102 103 104 105 420